pyrazines has been researched along with Diathesis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gesheva, VV; Nikolova-Ganeva, KA; Todorov, TA; Vassilev, TL; Voll, RE | 1 |
Cho, Y; Fujisawa, F; Hori, M; Kamoshita, M; Katsura, Y; Kojima, H; Komeno, T; Kudo, D; Mukai, HY; Okoshi, Y; Ota, I; Sasaki, K; Shimizu, S; Shinagawa, A; Tanaka, K; Yoshida, C | 1 |
Conrad, BL; Furuta, Y; Gowen, BB; Hickerson, BT; Jung, KH; Li, R; Miao, J; Nielson, S; Rigas, JD; Van Wettere, AJ; Wang, Z; Westover, JB | 1 |
Masmiquel Comas, L; Nicolau Ramis, J | 1 |
Jin, J; Li, Y; Meng, H; Qian, J; Tong, Y | 1 |
Dolan, PM; Itoh, K; Kensler, TW; Kwak, MK; Ramos-Gomez, M; Talalay, P; Yamamoto, M | 1 |
1 trial(s) available for pyrazines and Diathesis
Article | Year |
---|---|
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Boronic Acids; Bortezomib; Disease Susceptibility; Female; Follow-Up Studies; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Multiple Myeloma; Neoplasm Proteins; Peripheral Nervous System Diseases; Proteasome Endopeptidase Complex; Pyrazines | 2015 |
5 other study(ies) available for pyrazines and Diathesis
Article | Year |
---|---|
Targeted silencing of DNA-specific B cells combined with partial plasma cell depletion displays additive effects on delaying disease onset in lupus-prone mice.
Topics: Animals; Antibodies, Monoclonal; Autoantigens; B-Lymphocytes; Boronic Acids; Bortezomib; Cyclophosphamide; Disease Models, Animal; Disease Susceptibility; DNA; Female; Humans; Lupus Erythematosus, Systemic; Lymphocyte Depletion; Mice; Mice, Inbred MRL lpr; Peptide Fragments; Pyrazines; Receptors, IgG; Recombinant Fusion Proteins | 2013 |
Modeling Severe Fever with Thrombocytopenia Syndrome Virus Infection in Golden Syrian Hamsters: Importance of STAT2 in Preventing Disease and Effective Treatment with Favipiravir.
Topics: Amides; Animals; Animals, Genetically Modified; Antiviral Agents; Bunyaviridae Infections; Cricetinae; Disease Models, Animal; Disease Susceptibility; Genotype; Humans; Models, Biological; Phenotype; Phlebovirus; Pyrazines; STAT2 Transcription Factor | 2017 |
[The new antidiabetic agents in the firing line.... safety reasons or witch hunt?].
Topics: Animals; Breast Neoplasms; Calcitonin; Carcinoma, Medullary; Clinical Trials as Topic; Comorbidity; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Disease Susceptibility; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Infections; Liraglutide; Pancreatitis; Pharmacovigilance; Pioglitazone; Pyrazines; Risk Assessment; Safety-Based Drug Withdrawals; Sitagliptin Phosphate; Species Specificity; Thiazolidinediones; Thyroid Neoplasms; Triazoles; Urinary Bladder Neoplasms | 2012 |
The high incidence of varicella herpes zoster with the use of bortezomib in 10 patients.
Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Chickenpox; Dexamethasone; Disease Susceptibility; Doxorubicin; Female; Herpesvirus 3, Human; Humans; Incidence; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines; Virus Activation | 2007 |
Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice.
Topics: Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Carcinogenicity Tests; Carcinogens; Cell Nucleus; Disease Models, Animal; Disease Susceptibility; DNA-Binding Proteins; Epoxide Hydrolases; Female; FMN Reductase; Gene Expression; Genotype; Glucuronosyltransferase; Glutathione Transferase; Mice; Mice, Inbred ICR; Mice, Knockout; NADH, NADPH Oxidoreductases; NF-E2-Related Factor 2; Pyrazines; Stomach Neoplasms; Thiones; Thiophenes; Trans-Activators | 2001 |